Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8939418 | British Journal of Anaesthesia | 2006 | 8 Pages |
Abstract
These data indicate that a low, clinically relevant dose of ketamine offer significant neuroprotection during prolonged exposure to NMDA but not to NOC. Combinations of reduced doses of ketamine and TPS exhibited enhanced neuroprotection against NMDA-induced neurotoxicity. Hence, combinations of these two common i.v. anaesthetics agents could be developed to protect the brain from ischaemia.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
S. Shibuta, S. Varathan, T. Mashimo,